EMA Authorised: Tavneos (avacopan) — Vifor Fresenius Medical Care Renal Pharma France

View source ↗

Summary

The European Medicines Agency authorised Tavneos (avacopan) for microscopic polyangiitis and granulomatosis with polyangiitis (Wegener's granulomatosis), with V…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• TAVNEOS (avacopan)

Snippet

Status: Authorised. Therapeutic area: Microscopic Polyangiitis;Wegener Granulomatosis. MAH: Vifor Fresenius Medical Care Renal Pharma France. Decision date: 15/01/2025. Orphan medicine